Invention Grant
- Patent Title: Use of a VEGF antagonist to treat angiogenic eye disorders
- Patent Title (中): 使用VEGF拮抗剂治疗血管生成性眼病
-
Application No.: US13940370Application Date: 2013-07-12
-
Publication No.: US09254338B2Publication Date: 2016-02-09
- Inventor: George D. Yancopoulos
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Frank Cottingham; Karl Bozicevic
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/71 ; A61K47/48 ; A61K38/17 ; C07K16/22 ; A61K39/00
Abstract:
The present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a VEGF antagonist to a patient. The methods of the present invention include the administration of multiple doses of a VEGF antagonist to a patient at a frequency of once every 8 or more weeks. The methods of the present invention are useful for the treatment of angiogenic eye disorders such as age related macular degeneration, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion, branch retinal vein occlusion, and corneal neovascularization.
Public/Granted literature
- US20130295094A1 USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Public/Granted day:2013-11-07
Information query
IPC分类:
